Clinical Trial: Rifaximin Use in Severe Alcoholic Hepatitis
Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Effect of Gut Decontamination Using Rifaximin in the Patients With Severe Alcoholic Hepatitis
Brief Summary: This study aimed to investigate the effect of decontamination by rifaximin in severe alcoholic hepatitis patients. Patients who take corticosteroid or pentoxifylline will be randomly allocated to rifaximin group or control group.
Detailed Summary:
Sponsor: Saint Vincent's Hospital, Korea
Current Primary Outcome: Mortality [ Time Frame: 6-month ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Saint Vincent's Hospital, Korea
Dates:
Date Received: June 24, 2015
Date Started: July 2015
Date Completion:
Last Updated: June 25, 2015
Last Verified: June 2015